Part of Vanderbilt DRTC's Weekly Seminar Series
|Start Date / Time||December 8, 2017 at 12:00 PM|
|End Date / Time||December 8, 2017 at 1:00 PM|
|Location||206 Preston Research Building|
|Presenter Name||Matt Luther, MD, Vanderbilt University|
|Presentation Title||Epoxyeicosatrienoic Acid, CYP2C Metabolism, and Insulin Resistance in Humans|
|Status||This meeting has already occurred|
Assistant Professor of Medicine
Dr. Luther will discuss his translational studies in mice and in humans that test how the renin-angiotensin-aldosterone system and CYP450 monooxygenase system can impair insulin action, insulin secretion, and vascular function. He will also discuss their work in developing novel non-invasive biomarkers in humans to assess renal epithelial function.
Hosted by Sean Davies, PhD
© 2010-2017. All Rights Reserved to Vanderbilt University. Vanderbilt University is committed to principles of equal opportunity and affirmative action.
Released August 9, 2017